Bacterial Infections: all 665 studies

Page 2 of 7. Open to participants first (99), then studies with results posted, then the rest; newest registration first within each.

• Safety of Intravenous Apramycin in AdultsCompletedNCT05590728Phase 1Results posted
• Study to Evaluate the PK of IV and PO Omadacycline in Children and Adolescents With Suspected or Confirmed Bacterial InfectionsCompletedNCT05217537Phase 1Results posted
• Addition of Probenecid to Penicillin-V TherapyCompletedNCT05082909Phase 1/2Results posted
• Absorption, Elimination and Safety of 14C-labeled Radioactive BTZ-043, a New Compound in TB TreatmentCompletedNCT04874948Phase 1Results posted
• Predicting Severity and Disease Progression in Influenza-like Illness (Including COVID-19)TerminatedNCT04664075Results posted
• Drug-drug Interaction Study of GepotidacinCompletedNCT04493931Phase 1Results posted
• Antibiotic Selection Using Next Generation Sequencing vs Urine CultureCompletedNCT04404855Not applicableResults posted
• Pharmacokinetics of Ceftazidime-avibactam Among Critically-ill Patients Receiving CVVHDFCompletedNCT04358991Results posted
• Evaluation of Pharmacokinetics, Safety, and Tolerability of Ceftazidime-avibactam in Neonates and Infants.TerminatedNCT04126031Phase 2Results posted
• Pharmacokinetics of Gepotidacin Tablets in Adults and Adolescents SubjectsCompletedNCT04079790Phase 1Results posted
• A Trial to Evaluate the Pharmacokinetics and Safety of AVYCAZ(R) in Combination With AztreonamCompletedNCT03978091Phase 1/2Results posted
• TNP-2092 to Treat Acute Bacterial Skin and Skin Structure InfectionCompletedNCT03964493Phase 2Results posted
• Intravenous Fosfomycin Pharmacokinetics StudyCompletedNCT03910673Phase 1Results posted
• Contezolid Acefosamil Versus Linezolid for the Treatment of Acute Bacterial Skin and Skin Structure InfectionCompletedNCT03747497Phase 2Results posted
• Efficacy, Safety, and Tolerability of ATM-AVI in the Treatment of Serious Infection Due to MBL-producing Gram-negative BacteriaTerminatedNCT03580044Phase 3Results posted
• Pharmacokinetic Study of Oral Gepotidacin (GSK2140944) in Subjects With Uncomplicated Urinary Tract Infection (Acute Cystitis)CompletedNCT03568942Phase 2Results posted
• Pharmacokinetics (PK) Study of Gepotidacin (GSK2140944) in Adult Subjects With Varying Degrees of Hepatic Impairment and in Matched Control Subjects With Normal Hepatic FunctionCompletedNCT03562117Phase 1Results posted
• Early Kangaroo Mother Care in Gambian Hospitalised Unstable NeonatesTerminatedNCT03555981Not applicableResults posted
• Adjunctive Steps for Disinfection of Teeth With Primary Endodontic InfectionsCompletedNCT03537664Not applicableResults posted
• Bioequivalence Study Between SKF101804 Cefixime 200 Milligram (mg)/5 Milliliter (mL) Suspension Versus Cefixime 200 mg/5 mL Suspension Reference Product in Healthy Adult Subjects Under Fasting ConditionsCompletedNCT03408392Phase 1Results posted
• Minocycline Pharmacokinetics (ACUMIN)CompletedNCT03369951Phase 4Results posted
• Trial to Reduce Antimicrobial Use In Nursing Home Residents With Alzheimer's Disease and Other DementiasCompletedNCT03244917Not applicableResults posted
• Development of a New Critical Pathway for Treatment of Acute Bacterial Skin and Skin Structure Infections (ABSSSI)CompletedNCT03233438Phase 4Results posted
• A Pharmacokinetics Study of MK-7655A in Pediatric Participants With Gram-negative Infections (MK-7655A-020)CompletedNCT03230916Phase 1Results posted
• Bioequivalence Study Between GR37547 500 Milligrams (mg) Tablet Versus Ciprofloxacin 500 mg Tablet Reference Product in Healthy Adult SubjectsCompletedNCT03150082Phase 1Results posted
• Rifaximin Associated With Classic Triple Therapy for the Eradication of Helicobacter Pylori InfectionCompletedNCT03124199Phase 3Results posted
• Ecological Effect of Arginine Dentifrice on Oral MicrobiotaCompletedNCT02988349Not applicableResults posted
• An Observational Pharmacokinetic Sudy of Ceftolozane-Tazobactam in Intensive Care Unit in Patients With and Without CRRTCompletedNCT02962934Results posted
• Safety Evaluation of Seraph® 100 to Reduce Bacteremia in Patients on HemodialysisCompletedNCT02914132Not applicableResults posted
• Oral Omadacycline vs. Oral Linezolid for the Treatment of ABSSSICompletedNCT02877927Phase 3Results posted
• To Assess Bioavailability, Food Effect and Pharmacokinetics of Gepotidacin Tablets: A Phase I, Single-Dose, 2 Part Study in Healthy Subjects.CompletedNCT02853435Phase 1Results posted
• Dalbavancin for the Treatment of Acute Bacterial Skin and Skin Structure Infections in Children, Known or Suspected to be Caused by Susceptible Gram-positive Organisms, Including MRSACompletedNCT02814916Phase 3Results posted
• A Study to Evaluate Safety, Tolerability and Pharmacokinetics of Ascending Intravenous Single Dose and Repeat Dose of GSK3342830TerminatedNCT02751424Phase 1Results posted
• Pharmacokinetic Study of Gepotidacin in Subjects With Varying Degrees of Renal Impairment and in Subjects With Normal Renal FunctionCompletedNCT02729038Phase 1Results posted
• Extension Study to Evaluate the Immunogenicity and Safety of the Second Dose of GBS Trivalent Vaccine in Healthy Non-Pregnant Subjects.CompletedNCT02690181Phase 2Results posted
• Pharmacokinetics and Safety of Ceftobiprole in Neonates and Infants up to 3 Months Treated With Systemic AntibioticsTerminatedNCT02527681Phase 1Results posted
• Efficacy and Safety of Imipenem+Cilastatin/Relebactam (MK-7655A) Versus Colistimethate Sodium+Imipenem+Cilastatin in Imipenem-Resistant Bacterial Infection (MK-7655A-013)CompletedNCT02452047Phase 3Results posted
• Study to Assess Safety and Clinical Activity of Local MBN-101 in Treatment of Infected Bone SitesCompletedNCT02436876Phase 2Results posted
• Study of Debio 1450 for Bacterial Skin InfectionsCompletedNCT02426918Phase 2Results posted
• Omadacycline Versus Linezolid for the Treatment of ABSSSI (EudraCT #2013-003644-23)CompletedNCT02378480Phase 3Results posted
• Effect of Raxibacumab on Immunogenicity of Anthrax Vaccine AdsorbedCompletedNCT02339155Phase 4Results posted
• Larval Debridement Therapy Versus Sharp Debridement to Remove BiofilmCompletedNCT02294175Not applicableResults posted
• Topical Vancomycin for Neurosurgery Wound ProphylaxisCompletedNCT02284126Phase 3Results posted
• MRX-I Versus Linezolid for the Treatment of Acute Bacterial Skin and Skin Structure InfectionCompletedNCT02269319Phase 2Results posted
• Pharmacokinetic and Safety Study of Ceftolozane/Tazobactam in Pediatric Participants Receiving Antibiotic Therapy for Proven or Suspected Gram-negative Infection or for Peri-operative Prophylaxis (MK-7625A-010)CompletedNCT02266706Phase 1Results posted
• Efficacy and Safety of Intravenous to Oral 6-Day Tedizolid Phosphate vs. Intravenous to Oral 10-Day Linezolid in Patients With Acute Bacterial Skin and Skin Structure Infection (ABSSSI)CompletedNCT02066402Phase 3Results posted
• Dose-Ranging Study of GSK2140944 in the Treatment of Subjects With Suspected or Confirmed Gram-Positive Acute Bacterial Skin and Skin Structure InfectionsCompletedNCT02045797Phase 2Results posted
• Telavancin Pediatric PK Study (Ages >12 Months to 17 Years)TerminatedNCT02013141Phase 1Results posted
• Delafloxacin vs Vancomycin and Aztreonam for the Treatment of Acute Bacterial Skin and Skin Structure InfectionsCompletedNCT01984684Phase 3Results posted
• Spanish Mixed HEXA/PENTA/HEXA Schedule (V419-010)CompletedNCT01839188Phase 3Results posted
• Chlorhexidine Gluconate Cleansing in Preventing Central Line Associated Bloodstream Infection and Acquisition of Multi-drug Resistant Organisms in Younger Patients With Cancer or Undergoing Donor Stem Cell TransplantCompletedNCT01817075Phase 3Results posted
• Delafloxacin Versus Vancomycin and Aztreonam for the Treatment of Acute Bacterial Skin and Skin Structure InfectionsCompletedNCT01811732Phase 3Results posted
• Safety and Pharmacokinetics of Clindamycin in Pediatric Subjects With BMI ≥ 85th PercentileCompletedNCT01744730Phase 1Results posted
• To Investigate the Safety and Tolerability of Aztreonam-Avibactam (ATM-AVI)CompletedNCT01689207Phase 1Results posted
• Study of a Single Dose of SP093 Typhoid Vi Polysaccharide Vaccine in Japanese SubjectsCompletedNCT01608815Phase 3Results posted
• Post Marketing Surveillance Study on LinezolidCompletedNCT01564758Results posted
• Immunogenicity and Safety of V419 (PR51) in Combination With MCC in Infants and Toddlers (V419-011)CompletedNCT01553279Phase 3Results posted
• Effect of Xylitol on Oral Microbiota in ChildrenCompletedNCT01528969Phase 1/2Results posted
• Safety, Tolerability, and Immunogenicity of V419 in Healthy Infants When Given at 2, 4, and 11 to 12 Months (V419-008)CompletedNCT01480258Phase 3Results posted
• Immune Response Induced by a Vaccine Against Group B Streptococcus and Safety in Pregnant Women and Their OffspringsCompletedNCT01446289Phase 2Results posted
• Amoxicillin Bioequivalence Study Brazil - FastCompletedNCT01431989Phase 1Results posted
• TR-701 FA vs Linezolid for the Treatment of Acute Bacterial Skin and Skin Structure InfectionsCompletedNCT01421511Phase 3Results posted
• Magnitude of the Antibody Response to and Safety of a GBS Trivalent Vaccine in HIV Positive and HIV Negative Pregnant Women and Their OffspringsCompletedNCT01412801Phase 2Results posted
• Levofloxacin in Preventing Infection in Young Patients With Acute Leukemia Receiving Chemotherapy or Undergoing Stem Cell TransplantationCompletedNCT01371656Phase 3Results posted
• Safety, Tolerability, and Immunogenicity of V419 in Healthy Infants When Given at 2, 3, 4 and 12 Months (V419-007)CompletedNCT01341639Phase 3Results posted
• A Study of V419 Given Concomitantly With Prevnar 13™ and RotaTeq™ (V419-006)CompletedNCT01340937Phase 3Results posted
• Safety, Tolerability, and Immunogenicity of V419 Given Concomitantly With Prevnar 13™ and RotaTeq™ (V419-005)CompletedNCT01337167Phase 3Results posted
• A Study to Assess Objective Endpoint Measurements of Response in Bacterial Skin InfectionsCompletedNCT01283581Phase 2Results posted
• GSK1322322 Versus Linezolid in the Treatment of Acute Bacterial Skin and Skin Structure InfectionCompletedNCT01209078Phase 2Results posted
• Study Comparing the Safety and Efficacy of Two Doses of BC-3781 vs Vancomycin in Patients With Acute Bacterial Skin and Skin Structure Infection (ABSSSI)CompletedNCT01119105Phase 2Results posted
• Study of the Pharmacokinetics of Daptomycin in Children With Renal DiseaseCompletedNCT01012089Not applicableResults posted
• Zithromax-SR 2g, Special Investigation (Regulatory Post Marketing Commitment Plan)CompletedNCT00998309Results posted
• A Safety and Efficacy Study of Doripenem in Participants With Nosocomial Pneumonia, Complicated Intra-Abdominal Infections and Urinary Tract InfectionsCompletedNCT00965848Phase 4Results posted
• Bioequivalence Between Two Tablet Formulations Of Doxycycline CarragenateCompletedNCT00939562Phase 4Results posted
• Retapamulin Versus Linezolid in the Treatment of SITL and Impetigo Due to MRSACompletedNCT00852540Phase 3Results posted
• French Study In ICU Patients Treated With TigecyclineCompletedNCT00799591Results posted
• A Study To Assess The Effect Of Linezolid On QTc IntervalCompletedNCT00795145Phase 1Results posted
• Retapamulin Versus Placebo in Secondarily-Infected Traumatic Lesions (SITL)CompletedNCT00684177Phase 3Results posted
• Efficacy and Safety of Ceftaroline Versus Linezolid in Subjects With Complicated Skin and Skin Structure InfectionsCompletedNCT00633152Phase 2Results posted
• Study of AzaSite Versus Vigamox Concentrations in the Conjunctiva and Aqueous Humor in Subjects Undergoing Routine Cataract SurgeryCompletedNCT00575380Phase 4Results posted
• Study of AzaSite Versus Vigamox in the Tears of Healthy VolunteersCompletedNCT00575367Phase 4Results posted
• Study of AzaSite (Azithromycin) Versus Vigamox in the Conjunctiva of Healthy VolunteersCompletedNCT00564447Phase 4Results posted
• Pharmacokinetics of Retapamulin in Pediatric Subjects With Uncomplicated Skin Infections.CompletedNCT00555061Phase 4Results posted
• Retapamulin Ointment in Healthy Adults Nasally Colonized With Staphylococcus AureusCompletedNCT00539994Phase 2Results posted
• A Study of Ceftobiprole in Patients With Fever and Neutropenia.TerminatedNCT00529282Phase 3Results posted
• A Safety and Tolerability Study of Doripenem in Patients With Abdominal Infections or PneumoniaCompletedNCT00515034Phase 2Results posted
• Study to Evaluate the Efficacy and Safety of Moxifloxacin Versus Amoxicillin/Clavulanate in the Treatment of Acute Bacterial RhinosinusitisTerminatedNCT00493038Phase 4Results posted
• The Effects of Polymyxin-B Protects on Sepsis Induced Kidney Dysfunction: a Randomized Clinical TrialCompletedNCT00490477Phase 3Results posted
• Study Evaluating the Pharmacokinetics (PK), Safety, and Tolerability of Tigecycline in Patients 8 to 11 Years of AgeCompletedNCT00488345Phase 2Results posted
• Comparative Study of Ceftaroline vs. Vancomycin Plus Aztreonam in Adult Subjects With Complicated Skin InfectionsCompletedNCT00424190Phase 3Results posted
• Comparative Study of Ceftaroline vs. Vancomycin Plus Aztreonam in Adult Subjects With Complicated Skin InfectionsCompletedNCT00423657Phase 3Results posted
• Study Evaluating the Safety and Efficacy of a Once-daily Dose of Tigecycline vs Ertapenem in Diabetic Foot Infections (DFI) With a Substudy in Patients With Diabetic Foot Infections Complicated by Osteomyelitis.CompletedNCT00366249Phase 3Results posted
• Steroids for Corneal Ulcers TrialCompletedNCT00324168Phase 4Results posted
• A Study of Incidence of Musculoskeletal Disorders in Children Who Have Received Levofloxacin or a Standard Non-Fluoroquinolone Therapy for Acute Bacterial InfectionCompletedNCT00210639Results posted
• Human Neutrophil Lipocalin as an Aid in the Diagnosis of Bacterial Infection in the Emergency DepartmentCompletedNCT07796945
• A Study to Evaluate Safety and Efficacy of TP-05 in Healthy Participants With Tick ExposureActive, not recruitingNCT07562087Phase 2
• AI-Guided Proteomic Biomarker Panel for Differentiating Bacterial and Viral Infections in Acute Febrile IllnessCompletedNCT07205575
• EFFICACY OF PROLONGED INFUSION MEROPENEM IN CRITICALLY ILL PAEDIATRIC INTENSIVE CARE PATIENTSCompletedNCT07122596Phase 4
• A Study to Investigate Safety and Pharmacokinetics of Intravenous Cefiderocol/Xeruborbactam in Participants With Renal ImpairmentCompletedNCT07104162Phase 1
• A Study to Evaluate the Immunogenicity and Safety of 13-valent Pneumococcal Conjugate Vaccine (PCV13i) in Healthy Infants Aged 2 Months (Minimum 6 Weeks)Active, not recruitingNCT07017777Phase 3

← Bacterial Infections overview